Form 4: Director David Steinhaus Receives EBR Systems Stock Options

Director David Steinhaus was granted 34,211 stock options in EBR Systems, Inc. as part of a standard equity compensation arrangement.

Summary

• Director David Steinhaus acquired 34,211 stock options in EBR Systems, Inc. on May 6, 2026.
• The options have an exercise price of $3.7999 per share.
• The options are set to expire on May 5, 2036.
• Vesting occurs in 1/12 increments monthly, beginning June 6, 2026, contingent on continued service.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting standard director compensation practices.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Future value of options is dependent on the company's ability to maintain or grow its share price above the $3.7999 exercise price.

Future Outlook

The filing does not provide forward-looking business guidance, focusing solely on the equity compensation of a director.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices intended to incentivize long-term oversight and strategic alignment within the medical technology sector.

Comparison to Industry Standards

• The grant of stock options to non-executive directors is a common practice among publicly traded medical device companies to ensure retention and alignment.
• The 10-year expiration term is consistent with standard equity incentive plan designs.

Stakeholder Impact

• Minimal impact on existing shareholders; represents standard dilution management.

Next Steps

• Vesting of options to commence on June 6, 2026.

Key Dates

Keywords

EBR Systems, Director Compensation, Stock Options, Insider Transaction, Form 4